← All organizations

Intergroupe Francophone du Myelome

Academic/HospitalWebsite ↗

Also known as: Intergroupe Francophone du Myelome

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jul 9, 2025

Timeline

1990s

Jan 1, 1994
Intergroupe Francophone du Myelome— Founded

Drugs by trial phase (14 distinct, 13 trials)

Phase 3 (8 own, 0 via acquisition)

Phase 2 (4 own, 0 via acquisition)

Other trials (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (13)

NCT06918002Lead sponsorPhase 3Jul 9, 2025
NCT05066607Lead sponsorPhase 2Dec 31, 2021
NCT04934475Lead sponsorPhase 3Sep 1, 2021
NCT04751877CollaboratorPhase 3Jul 17, 2021
NCT03683277Lead sponsorPhase 2Oct 1, 2018
NCT02626481CollaboratorPhase 2Dec 1, 2015
NCT02541383Lead sponsorPhase 3Sep 1, 2015
NCT02244125CollaboratorPhase 2Apr 1, 2014
NCT01045681Lead sponsorPhase 2Jan 1, 2010
NCT00907452Lead sponsorN/AApr 1, 2009
NCT00910897Lead sponsorPhase 3Mar 1, 2008
NCT00642395CollaboratorPhase 2Jul 1, 2007
NCT00430365CollaboratorPhase 3Jun 1, 2006

Details

Founded: Paris, FR Jan 1, 1994
Last known activity: Jul 9, 2025